Microparticles in stored red blood cells: Submicron clotting bombs?

Blood Transfusion

Volumn 8, Issue SUPPL. 3, 2010, Pages

  Rubin, Olivier ^a   Crettaz, David ^a   Tissot, Jean Daniel ^a   Lion, Niels ^a  

^a Service Regional Vaudois de Transfusion Sanguine   (Switzerland)

Author keywords

Blood storage; Coagulation; Microparticles; Red blood cells

Indexed keywords

BLOOD CLOTTING; BLOOD COMPONENT; ERYTHROCYTE PRESERVATION; HYPERCOAGULABILITY; PROTEOMICS; REVIEW;

BLOOD COAGULATION; BLOOD PRESERVATION; CELL-DERIVED MICROPARTICLES; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS;

EID: 78049234349     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2010.006S     Document Type: Review

References (58)

1. Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004; 34: 392-401.
2. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006; 20: 1-26.
3. Lu JH, Liu XF, Shao WX, et al. Phylogenetic analysis of eight genes of H9N2 subtype influenza virus: a mainland China strain possessing early isolates' genes that have been circulating. Virus Genes 2005; 31: 163-9.
4. Morel O, Toti F, Hugel B, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006; 26: 2594-604.
5. Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem 1999; 274: 23111-8. (Pubitemid 29388057)
6. Brill A, Dashevsky O, Rivo J, et al. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 2005; 67: 30-8.
7. Lion N, Crettaz D, Rubin O, Tissot JD. Stored red blood cells: A changing universe waiting for its map(s). J Proteomics 2009; 73: 374-85.
8. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157-71.
9. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59: 277-87.
10. Ogata N, Imaizumi M, Nomura S, et al. Increased levels of platelet-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract 2005; 68: 193-201.
11. Van Beers EJ, Schaap MC, Berckmans RJ, et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009; 94: 1513-9.
12. Ataga KI. Hypercoagulability and thrombotic complications in hemolytic anemias. Haematologica 2009; 94: 1481-4.
13. Soriano AO, Jy W, Chirinos JA, et al. Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Crit Care Med 2005; 33 : 2540-6. (Pubitemid 41682106)
14. Noland JS. Executive functioning demands of the object retrieval task for 8-month-old infants. Child Neuropsychol 2008; 14: 504-9.
15. Lawrie AS, Albanyan A, Cardigan RA, et al. Microparticle sizing by dynamic light scattering in fresh-frozen plasma. Vox Sang 2009; 96: 206-12.
16. Thomas S, Beard M, Garwood M, et al. Platelet concentrates produced from whole blood using the Atreus processing system. Vox Sang 2009; 97: 93-101.
17. Rubin O, Crettaz D, Canellini G, et al. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 2008; 95: 288-97.
18. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-32.
19. Blostein MD, Furie BC, Rajotte I, Furie B. The Gla domain of factor IXa binds to factor VIIIa in the tenase complex. J Biol Chem 2003; 278: 31297-302.
20. Furie B, Furie BC. In vivo thrombus formation. J Thromb Haemost 2007; 5: 12-7.
21. Nesheim ME, Taswell JB, Mann KG. The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. J Biol Chem 1979; 254: 10952-62.
22. Mertens K, Bertina RM. The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX. Biochem J 1984; 223: 607-15.
23. Kini RM. Structure-function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venoms. Toxicon 2005; 45: 1147-61.
24. Sinauridze EI, Kireev DA, Popenko NY, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97: 425-34.
25. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-49.
26. Chung SM, Bae ON, Lim KM, et al. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol 2007; 27: 414-21.
27. Osterud B, Olsen JO, Bjorklid E. What is blood borne tissue factor? Thromb Res 2009; 124: 640-1.
28. Connor DE, Exner T, Ma DD, Joseph JE. Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT. Blood Coagul Fibrinolysis 2009; 20: 558-564.
29. Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003; 102: 2678-83. (Pubitemid 37193612)
30. Trappenburg MC, van Schilfgaarde M, Marchetti M, et al. Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia. Haematologica 2009; 94: 911-8.
31. Mobarrez F, Antovic J, Egberg N, et al. A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res 2009; 1: 2561-8.
32. Biro E, Sturk-Maquelin KN, Vogel GM, et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003; 1: 2561-8.
33. Jy W, Horstman LL, Jimenez JJ, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1842-51.
34. Heit JA. Thrombophilia: common questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program 2007; 2007: 127-35.
35. Ataga KI, Cappellini MD, Rachmilewitz EA. Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability. Br J Haematol 2007; 139: 3-13.
36. Tripodi A, Cappellini MD, Chantarangkul V, et al. Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma. Haematologica 2009; 94: 1520-7.
37. Bosman GJ, Werre JM, Willekens FL, Novotny VM. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 2008; 18: 335-47.
38. Bennett-Guerrero E, Veldman TH, Doctor A, et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A 2007; 104: 17063-8.
39. Willekens FL, Werre JM, Kruijt JK, et al. Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood 2005; 105: 2141-5.
40. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006; 20: 1-26. (Pubitemid 41811224)
41. Willekens FL, Werre JM, Groenen-Dopp YA, et al. Erythrocyte vesiculation: a self-protective mechanism? Br J Haematol 2008; 141: 549-56.
42. Nauta AJ, Trouw LA, Daha MR, et al. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol 2002; 32: 1726-36.
43. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-39.
44. Spinella PC, Carroll CL, Staff I, et al. Duration of red blood cell storage is associated with increased incidence of deep vein thrombosis and in hospital mortality in patients with traumatic injuries. Crit Care 2009; 13: R151.
45. Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116: 2544-52.
46. Bernard AC, Davenport DL, Chang PK, et al. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009; 208: 931-7.
47. Adamson JW. New blood, old blood, or no blood? N Engl J Med 2008; 358: 1295-6.
48. Benjamin RJ, Dodd RY. Red-cell storage and complications of cardiac surgery. N Engl J Med 2008; 358: 2840-1.
49. Frenzel T, Sibrowski W, Westphal M. Red-cell storage and complications of cardiac surgery. N Engl J Med 2008; 358: 2841-2.
50. Habib RH, Zacharias A. Red-cell storage and complications of cardiac surgery. N Engl J Med 2008; 358: 2841-2.
51. Hess JR. Red cell storage. J Proteomics 2010; 73: 368-373.
52. Garcia BA, Smalley DM, Cho H, et al. The platelet microparticle proteome. J Proteome Res 2005; 4: 1516-21.
53. Bosman GJ, Lasonder E, Luten M, et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 2008; 48: 827-35. (Pubitemid 351614907)
54. Pasini EM, Kirkegaard M, Mortensen P, et al. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 2006; 108: 791-801.
55. Jin M, Drwal G, Bourgeois T, et al. Distinct proteome features of plasma microparticles. Proteomics 2005; 5: 1940-52.
56. Banfi C, Brioschi M, Wait R, et al. Proteome of endothelial cell-derived procoagulant microparticles. Proteomics 2005; 5: 4443-55.
57. Miguet L, Pacaud K, Felden C, et al. Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics 2006; 6: 153-71. (Pubitemid 43142942)
58. Rabilloud T, Detergents and chaotropes for protein solubilization before two dimensional electrophoresis, Methods Mol Biol 2009; 528: 259-67.